Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Pedro Henrique de Caires SchlugaLaboratório de Matriz Extracelular e Biotecnologia de Venenos, Universidade Federal do Paraná, UFPR, Curitiba 81531-980, Brazil.ORCID 0000-0002-8454-7454
Debora LarangoteLaboratório de Toxinologia de Venenos Animais, Fundação Ezequiel Dias, FUNED, Belo Horizonte 30510-010, Brazil.ORCID 0000-0002-7141-7765
Ana Maria de MeloLaboratório de Matriz Extracelular e Biotecnologia de Venenos, Universidade Federal do Paraná, UFPR, Curitiba 81531-980, Brazil.
Guilherme Kamienski LobermayerLaboratório de Matriz Extracelular e Biotecnologia de Venenos, Universidade Federal do Paraná, UFPR, Curitiba 81531-980, Brazil.
Daniel TorrejónLaboratorio de Biología Molecular, Facultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0001-9385-6921
Luciana Souza de OliveiraLaboratório de Toxinologia de Venenos Animais, Fundação Ezequiel Dias, FUNED, Belo Horizonte 30510-010, Brazil.ORCID 0000-0002-2784-5658
Valeria Gonçalves AlvarengaLaboratório de Toxinologia de Venenos Animais, Fundação Ezequiel Dias, FUNED, Belo Horizonte 30510-010, Brazil.ORCID 0000-0003-2631-4182
Dan Erick Vivas-RuizLaboratorio de Biología Molecular, Facultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0003-4417-2026
Silvio Sanches VeigaLaboratório de Matriz Extracelular e Biotecnologia de Venenos, Universidade Federal do Paraná, UFPR, Curitiba 81531-980, Brazil.
Eladio Flores SanchezLaboratório de Toxinologia de Venenos Animais, Fundação Ezequiel Dias, FUNED, Belo Horizonte 30510-010, Brazil.
Luiza Helena GremskiLaboratório de Matriz Extracelular e Biotecnologia de Venenos, Universidade Federal do Paraná, UFPR, Curitiba 81531-980, Brazil.
Funding
Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-00071-21Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-01724-18Fundação de Amparo à Pesquisa do Estado de Minas Gerais BIP-00004-24Fundação de Amparo à Pesquisa do Estado de Minas Gerais BIP-00040-23National Council for Scientific and Technological Development 303150/2021-1National Council for Scientific and Technological Development 309823/2021-8National Council for Scientific and Technological Development 405013/2021-3Pro Ciencia Peru PE501088550-2024-ProcienciaUniversidade Federal do Paraná 03/2023
6 · The paper itself
Abstract
Viperid snake venoms are notably abundant in metalloproteinases (proteins) (SVMPs), which are primarily responsible for inducing hemorrhage and disrupting the hemostatic process and tissue integrity in envenomed victims. In this study, barnettlysin-III (Bar-III), a hemorrhagic P-III SVMP, was purified from the venom of the Peruvian snake
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Novel P-III Metalloproteinase from · full record | OpenQuestion